AGL 38.51 Increased By ▲ 0.03 (0.08%)
AIRLINK 202.89 Decreased By ▼ -0.13 (-0.06%)
BOP 10.06 Decreased By ▼ -0.11 (-1.08%)
CNERGY 6.43 Decreased By ▼ -0.11 (-1.68%)
DCL 9.49 Decreased By ▼ -0.09 (-0.94%)
DFML 39.70 Decreased By ▼ -0.32 (-0.8%)
DGKC 99.05 Increased By ▲ 0.97 (0.99%)
FCCL 35.70 Increased By ▲ 0.74 (2.12%)
FFBL 88.25 Increased By ▲ 1.82 (2.11%)
FFL 13.65 Decreased By ▼ -0.25 (-1.8%)
HUBC 130.40 Decreased By ▼ -1.17 (-0.89%)
HUMNL 14.10 Increased By ▲ 0.08 (0.57%)
KEL 5.49 Decreased By ▼ -0.12 (-2.14%)
KOSM 7.51 Increased By ▲ 0.24 (3.3%)
MLCF 46.25 Increased By ▲ 0.66 (1.45%)
NBP 61.52 Decreased By ▼ -4.86 (-7.32%)
OGDC 219.81 Decreased By ▼ -0.95 (-0.43%)
PAEL 40.24 Increased By ▲ 1.76 (4.57%)
PIBTL 8.70 Decreased By ▼ -0.21 (-2.36%)
PPL 196.50 Decreased By ▼ -1.38 (-0.7%)
PRL 39.17 Increased By ▲ 0.14 (0.36%)
PTC 25.75 Increased By ▲ 0.28 (1.1%)
SEARL 105.60 Increased By ▲ 2.55 (2.47%)
TELE 8.94 Decreased By ▼ -0.08 (-0.89%)
TOMCL 36.24 Decreased By ▼ -0.17 (-0.47%)
TPLP 14.00 Increased By ▲ 0.25 (1.82%)
TREET 24.75 Decreased By ▼ -0.37 (-1.47%)
TRG 57.90 Decreased By ▼ -0.14 (-0.24%)
UNITY 33.54 Decreased By ▼ -0.13 (-0.39%)
WTL 1.67 Decreased By ▼ -0.04 (-2.34%)
BR100 11,940 Increased By 50 (0.42%)
BR30 37,325 Decreased By -31.5 (-0.08%)
KSE100 110,549 Decreased By -521.6 (-0.47%)
KSE30 34,762 Decreased By -146.8 (-0.42%)
Pakistan

Interior Minister Ijaz Shah gets first dose of COVID-19 trial vaccine

  • UHS Vice-Chancellor Prof Javed Akram says the minister’s staff members were also administered the trial vaccine
  • China had supplied the medication, developed by Chinese biotech CanSinoBio in partnership with the Beijing Institute of Biotechnology, to Islamabad as part of a trial agreement
Published December 7, 2020

(Karachi) Federal Interior Minister Ijaz Shah has been administered trial vaccine of COVID-19 from China at the University of Health Sciences (UHS) Lahore, local media reported on Monday.

“Interior Minister Ijaz Shah was administered the vaccine, which has been in phase three of clinical trials,” UHS Vice-Chancellor Prof Dr Javed Akram said.

“The minister’s staff members were also administered the trial vaccine,” Prof Akram added.

Earlier, Pakistan began final-phase testing of a Chinese-made vaccine against novel coronavirus, the first ever clinical trial of its kind in the South Asian nation.

China had supplied the COVID-19 medication, developed by Chinese biotech CanSinoBio in partnership with the Beijing Institute of Biotechnology, to Islamabad as part of a trial agreement.

So far, the trial vaccine has seen a positive public response, raising the hope that the effort would meet its target. The specific vaccine has already established its safety and efficacy in the previous trials held in China with no serious adverse effects.

It’s now being tested on a wider population in Russia, Mexico, Chile, Argentina, Saudi Arabia and Pakistan; the country has been allocated 8,000 recruits out of a total of 40,000 and is currently conducting the trial at five centres in Islamabad, Lahore and Karachi.

Comments

Comments are closed.